Related by context. All words. (Click for frequent words.) 76 alvespimycin 76 PEG Interferon lambda 76 docetaxel Taxotere R 76 pomalidomide 75 pertuzumab 75 nalbuphine ER 75 dacetuzumab 75 phase IIb 75 ocrelizumab 75 HGS# 75 tanespimycin 75 galiximab 75 evaluating tivozanib 75 phase IIb trial 75 atacicept 75 forodesine 74 HuLuc# 74 neratinib 74 MAGE A3 ASCI 74 JAK inhibitor 74 Bicifadine 74 Phase Ib study 74 Phase Ib clinical 74 ularitide 74 Archexin 74 deforolimus 74 PRT# 74 bicifadine 74 lumiliximab 73 HuMax CD4 73 FOLOTYN ® 73 oral prodrug 73 HGS ETR2 73 custirsen 73 otelixizumab 73 Dacogen injection 73 Traficet EN 73 regorafenib 73 ELACYT 73 iniparib 73 Aflibercept 73 enzastaurin 73 phase IIa clinical 73 phase IIb clinical 73 fostamatinib 73 HuMax CD# 73 GSK# [002] 73 BCX# 73 lomitapide 73 HGS ETR1 73 MGd 73 daclizumab 73 mapatumumab 73 GSK# [001] 73 oxymorphone ER 73 metaglidasen 73 IMA# 73 CIMZIA TM 73 teriflunomide 73 Velcade bortezomib 73 axitinib 73 Plicera 73 interferon gamma 1b 73 compound INCB# 73 RSD# oral 72 posaconazole 72 pradefovir 72 PDE4 inhibitor 72 Azedra 72 AEGR 72 valopicitabine 72 Asentar 72 TBC# 72 Amrubicin 72 sorafenib Nexavar 72 virus HCV protease inhibitor 72 SPRYCEL ® 72 YONDELIS 72 ponatinib 72 midstage clinical 72 Panzem R NCD 72 SAR# [004] 72 PEG SN# 72 BAY #-# 72 celgosivir 72 cediranib 72 HuMax EGFr 72 AEG# 72 Telintra 72 methylnaltrexone 72 HER2 positive metastatic breast 72 PXD# 72 vidofludimus 72 eniluracil 72 riociguat 72 Ixempra 72 baminercept 72 amrubicin 72 registrational trial 72 Androxal TM 72 TELCYTA 72 Fibrillex TM 72 Zolinza 72 teduglutide 72 Dapagliflozin 72 reslizumab 72 LymphoStat B 72 XmAb# 72 LAF# 72 MAXY alpha 72 ZOLINZA 72 apremilast 72 sunitinib malate 72 HCD# [002] 71 atrasentan 71 cilengitide 71 docetaxel chemotherapy 71 Targretin 71 trastuzumab Herceptin R 71 non nucleoside HCV 71 Phase IIIb clinical 71 TELINTRA 71 ofatumumab 71 MGCD# [001] 71 Phase Ib II 71 lintuzumab 71 vicriviroc 71 talactoferrin 71 standard chemotherapy regimen 71 Daclizumab 71 refractory gout 71 bortezomib Velcade 71 romidepsin 71 budesonide foam 71 Mipomersen 71 bardoxolone 71 ACTEMRA TM 71 EndoTAG TM -1 71 visilizumab 71 sitaxsentan 71 eltrombopag 71 lenalidomide dexamethasone 71 LymphoStat B belimumab 71 ganetespib 71 gefitinib Iressa 71 INCB# [001] 71 R# #mg BID 71 huC# DM4 71 adecatumumab MT# 71 Dasatinib 71 Vitaxin 71 Aptivus ® 71 beta 1a 71 cannabinor 71 R#/MEM # 71 Tarceva TM 71 dextromethorphan quinidine 71 thalidomide Thalomid 71 investigational humanized monoclonal antibody 71 receptor tyrosine kinase inhibitor 71 ancrod 71 Amplimexon 71 Pimavanserin 71 proteasome inhibitor 71 SinuNase ™ 71 lesinurad 71 Phase IIa trials 71 CANCIDAS 71 darapladib 71 GW# [003] 71 Factor VIIa 71 multicenter Phase II 71 Nexavar sorafenib 71 zanolimumab 71 Phase #/#a 71 RGB # 71 entinostat 71 TLK# 71 CCX# 70 Bezielle 70 Phenoptin 70 relapsed MM 70 relapsed multiple myeloma 70 confirmatory Phase III 70 CoFactor 70 Zenvia ™ 70 oral ridaforolimus 70 danoprevir 70 elagolix 70 sargramostim 70 Nuvion 70 IRX 2 70 dose cohort 70 volociximab 70 Gemzar ® 70 FOLFOX6 chemotherapy regimen 70 Panitumumab 70 TACI Ig 70 trastuzumab emtansine T DM1 70 docetaxel Taxotere ® 70 lintuzumab SGN 70 adecatumumab 70 ISTODAX 70 TNF antagonist 70 diabetic neuropathic pain 70 alvimopan 70 mertansine 70 LY# [003] 70 nonclinical studies 70 ARIKACE ™ 70 cetuximab Erbitux R 70 BRAF inhibitor 70 APTIVUS r 70 IAP inhibitors 70 sorafenib tablets 70 Annamycin 70 dasatinib Sprycel ® 70 PSN# [002] 70 CIMZIA ™ 70 PLK1 SNALP 70 phase Ib 70 docetaxel Taxotere 70 Nexavar ® 70 OvaRex ® MAb 70 PSMA ADC 70 GAMMAGARD 70 Tasimelteon 70 CR# vcMMAE 70 tolvaptan 70 Ocrelizumab 70 Xanafide 70 Phase 1b trial 70 Allovectin 7 70 TORISEL 70 Genentech Rituxan 70 trastuzumab DM1 T DM1 70 evaluating satraplatin 70 UVIDEM 70 lixivaptan 70 Phase IIb clinical trials 70 Pertuzumab 70 desvenlafaxine succinate 70 erlotinib Tarceva ® 70 dirucotide 70 phase IIa 70 EOquin TM 70 vandetanib 70 KNS # 70 glufosfamide 70 KRN# 70 ZACTIMA 70 rilonacept 70 brivaracetam 70 adalimumab Humira 70 Phase 2a trial 70 PROMACTA 70 DermaVir Patch 70 GALNS 70 MKC# MT 70 oxaliplatin Eloxatin 70 Azedra TM 70 figitumumab 70 motesanib 70 NATRECOR ® 70 etanercept Enbrel 70 ALN PCS 70 Randomized Phase 70 TRX1 70 ATL/TV# 70 Epratuzumab 70 Ereska 70 eritoran 70 bendamustine 70 BRIM2 70 investigational monoclonal antibody 70 PANVAC VF 70 JAK2 inhibitor 70 IL# PE#QQR 70 PHX# 70 perampanel 70 pegylated interferons 70 velafermin 70 histone deacetylase HDAC inhibitor 69 Ozarelix 69 diarrhea predominant irritable 69 Phase 2b study 69 Canvaxin 69 oral deforolimus 69 INTEGRILIN 69 RAPTIVA 69 XL# XL# 69 CIMZIA TM certolizumab pegol 69 Syncria 69 AVASTIN 69 Cimzia TM 69 Atrasentan 69 Sym# 69 incyclinide 69 Viramidine 69 mGluR5 NAM 69 IMC #B 69 DEB# 69 PREOS 69 gemcitabine Gemzar 69 ACAPODENE 69 opioid induced bowel dysfunction 69 Panzem R 69 registrational 69 Phase #b/#a 69 tesmilifene 69 panitumumab Vectibix 69 including eniluracil ADH 69 PS# [001] 69 mycophenolate mofetil 69 cinacalcet HCl 69 infusional 5-FU/LV 69 Phase Ib 69 Actilon 69 APTIVUS 69 ATL# [001] 69 SILENOR 69 pegylated liposomal doxorubicin 69 Phase IIb trials 69 liposomal formulation 69 Neulasta ® 69 PREOS R 69 Xcytrin R 69 non nucleoside inhibitor 69 HQK 69 tenofovir emtricitabine 69 RITUXAN 69 metastatic hormone refractory 69 cancer neuroendocrine tumor 69 lapatinib Tykerb 69 RELOVAIR ™ 69 Rebif ® 69 Aplidin 69 decitabine 69 nab paclitaxel 69 Alocrest 69 PEG PAL 69 elacytarabine 69 CYT# potent vascular disrupting 69 ASONEP 69 dose cohorts 69 Nanobody 69 Quinamed 69 Tanespimycin 69 LE DT 69 L BLP# 69 Troxatyl 69 ORENCIA R 69 PEGylated interferon beta 1a 69 erlotinib Tarceva 69 vosaroxin 69 TYZEKA 69 Neurodex 69 XL# XL# XL# XL# 69 CD# CEA 69 ofatumumab HuMax CD# 69 urocortin 2 69 muraglitazar 69 Onconase 69 metastatic castration resistant 69 canakinumab 69 vismodegib 69 Phase 1a clinical 69 rindopepimut 69 AQ4N 69 Tesmilifene 69 IMC A# 69 Saforis 69 paclitaxel Taxol ® 69 ONCONASE R 69 MERLIN TIMI 69 OXi# 69 albinterferon alfa 2b 69 Pazopanib 69 rNAPc2 69 Aloxi injection 69 ONTAK 69 Insegia 69 NXL# 69 Azilect ® 69 oral methylnaltrexone 69 REMINYL ® 69 alkylating agent 69 Elotuzumab 69 Zemplar Capsules 69 fenofibric acid 69 BRIM3 69 oral salmon calcitonin 69 bosutinib 69 aprepitant 69 tremelimumab 69 EOquin 69 EDEMA3 69 Genz # 69 pan HDAC inhibitor 69 certolizumab 69 Cinquil 69 TKM ApoB 69 NATRECOR R 69 Phase 2b clinical 69 Cloretazine R VNP#M 69 xanthine oxidase inhibitor 69 Teriflunomide 69 Phase 1b 69 octreotide acetate 69 PF # [002] 68 Ostarine 68 dexpramipexole 68 EndoTAGTM 1 68 subcutaneous formulation 68 severe hypercholesterolemia 68 ELND# 68 6R BH4 68 OHR/AVR# 68 Elagolix 68 QVA# 68 blinatumomab 68 obatoclax 68 Phase IIB 68 radiation sensitizer 68 EDEMA3 trial 68 CTAP# Capsules 68 LymphoStat B TM 68 Symadex 68 azilsartan medoxomil 68 Phase 2b trial 68 Desmoteplase 68 Phase 1b clinical trials 68 R sorafenib tablets 68 HCV RESPOND 2 68 AGILECT R 68 GFT# 68 THALOMID 68 Aurexis 68 torsemide ER 68 TYGACIL 68 midstage trials 68 huN# DM1 68 HCV protease inhibitor 68 dimebon 68 Omacetaxine 68 belinostat 68 PEG IFN 68 DDP# 68 Pruvel 68 telaprevir VX 68 Hedgehog antagonist 68 Proxinium TM 68 Revlimid lenalidomide 68 Corlux 68 Laquinimod 68 SinuNase 68 leukemia AML 68 Meets Primary Endpoint 68 MNTX 68 multicenter Phase III 68 palonosetron 68 Reverset 68 Taxotere ® 68 refractory chronic lymphocytic 68 Targretin capsules 68 metastatic CRC 68 aflibercept 68 Bortezomib 68 Sulonex 68 LHRH antagonists 68 TRO# 68 ToGA 68 TOCOSOL Paclitaxel 68 motesanib diphosphate 68 Initiate Phase 68 terlipressin 68 sorafenib Nexavar ® 68 ixabepilone 68 AzaSite Plus 68 ISIS # 68 pioglitazone HCl 68 ASA# 68 pharmacokinetic PK study 68 AVONEX ® 68 CD3 monoclonal antibody 68 vemurafenib 68 MYCAMINE 68 DU #b 68 RSD# 68 ATACAND 68 torezolid phosphate 68 AAG geldanamycin analog 68 irbesartan 68 LEP ETU 68 Pivotal Phase 68 tolevamer 68 investigational protease inhibitor 68 alpha 2a 68 Glatiramer Acetate 68 Tyrima 68 cobiprostone 68 XL# anticancer compounds 68 cathepsin K inhibitor 68 thymalfasin 68 varespladib 68 Amigal 68 Proellex TM 68 STRIDE PD 68 Rigel R# 68 Phase 1b clinical 68 Vilazodone 68 PNP inhibitor 68 MyVax R 68 ARB telmisartan 68 Phase 2b clinical trials 68 chlorambucil 68 febuxostat 68 ORENCIA ® 68 glatiramer 68 tocilizumab 68 CBLC# 68 Adentri 68 Torisel 68 ALN TTR 68 cabazitaxel 68 Eltrombopag 68 CytoFabTM 68 ridaforolimus 68 Fludara 68 BENICAR HCT 68 Cetrorelix 68 miconazole Lauriad ® 68 MEK inhibitor 68 Unit Dose Budesonide 68 trastuzumab DM1 68 Muraglitazar 68 #D#C# 68 Entereg R 68 HCV SPRINT 68 sapacitabine 68 tramiprosate Alzhemed TM 68 Leukine ® 68 Cloretazine ® 68 SNT MC# 68 Aurora kinase inhibitor 68 multicenter Phase 68 ALN VSP Phase 68 DPX Survivac 68 cetuximab Erbitux 68 prucalopride 68 Allovectin 7 ® 68 RhuDex TM 68 epothilone 68 phase IIb study 68 pegylated interferon alpha 68 refractory CLL 68 Tocosol Paclitaxel 68 IV Busulfex 68 cangrelor 68 Oral NKTR 68 Allovectin 7 R 68 Vernakalant 68 ulimorelin 68 Teplizumab 68 Xinlay 68 Pemetrexed 68 rasagiline tablets 68 ACZ# 68 XL# XL# XL# 68 tipranavir 68 temsirolimus 68 viral kinetic 68 aleglitazar 68 VELCADE melphalan 68 abiraterone acetate 68 assessing T DM1 68 AZD# 68 NVA# 68 acyclovir Lauriad R 68 glatiramer acetate 68 PrevOnco 68 Chemophase 68 Temsirolimus 68 refractory AML 68 mRCC 68 IIIa inhibitor 68 gemcitabine Gemzar ® 68 selective androgen receptor modulator 68 YERVOY 68 Tezampanel 68 Dacogen decitabine 68 briakinumab 68 efalizumab 68 Telcyta 68 IPL# 68 Lenocta 68 OncoVEX GM CSF 68 Imprime PGG 68 LY# [002] 68 Urocortin 2 68 ProSavin 68 anticancer compound 68 micafungin 68 TriRima 68 nucleoside analog 68 Octreolin 68 IMiDs 68 Zybrestat 68 Ambrisentan 68 RhuDex ® 68 Diamyd ® 67 candidate CRLX# 67 talabostat 67 Leukine 67 Phase 2a clinical 67 Romidepsin 67 MT#/MEDI-# 67 tecarfarin 67 Phase IIb clinical 67 TREANDA 67 CDP# 67 Exelixis compounds 67 ALGRX 67 USL# 67 GOUT 67 ENMD # 67 Onco TCS 67 maximally tolerated dose 67 CD# antibody [001] 67 SinuNase TM 67 tipifarnib 67 Vicriviroc 67 desvenlafaxine 67 Ophena TM 67 orally administered inhibitor 67 comparator arm 67 novel VDA molecule 67 phase IIb III 67 Personalized Immunotherapy 67 ruxolitinib 67 Phase IIa trial 67 Acapodene 67 Pivotal Phase III 67 dasatinib Sprycel 67 investigational oral anticoagulant 67 tiapamil 67 CLORETAZINE TM VNP#M 67 methylnaltrexone bromide 67 Darusentan 67 IMiDs ® 67 Trastuzumab DM1 67 ARCOXIA 67 edoxaban 67 Cleviprex TM clevidipine 67 sorafenib Nexavar R 67 demonstrated antitumor activity 67 ongoing Phase 1b 67 Apoptone 67 GRN#L 67 Omnitarg 67 NP2 Enkephalin 67 SUTENT 67 relapsed MCL 67 romiplostim 67 Tavocept 67 Evoltra ® 67 NUVIGIL 67 beta interferons 67 goserelin 67 R#/MEM 67 Neulasta R 67 ritonavir boosted 67 JAK inhibitors 67 Octreotide 67 Phase Ib clinical trials 67 alemtuzumab Campath 67 cariprazine 67 polymerase inhibitor 67 elesclomol 67 Glufosfamide 67 Vidaza ® 67 NO# [002] 67 MEND CABG II 67 AeroLEF TM 67 oral rivaroxaban 67 UPLYSO 67 adenosine injection 67 INTELENCE 67 ITAX 67 boosted protease inhibitor 67 Lu AA# 67 relapsed refractory multiple myeloma 67 ApoB SNALP 67 Vfend 67 aclidinium 67 ospemifene 67 REVLIMID ® 67 HCV polymerase inhibitors 67 tafamidis 67 Lixivaptan 67 Tekturna HCT 67 Dextofisopam 67 PRE SURGE 67 ketolide antibiotic 67 recurrent glioblastoma multiforme 67 Raptiva R 67 PROSTVAC VF 67 ruboxistaurin 67 Anacetrapib 67 nucleotide analog 67 TASKi2 67 OMNARIS Nasal Spray 67 AVE# 67 Fludara ® 67 Alzhemed TM 67 Xeloda ® 67 Stimuvax R 67 Ticagrelor 67 TMC# C# 67 PI3K/Akt pathway inhibitor 67 Alvesco R 67 latrepirdine 67 Inhalation Solution 67 SUCCEED trial 67 bortezomib Velcade R 67 Multiple Ascending Dose 67 maribavir 67 Doxil ® 67 palifosfamide 67 placebo controlled clinical 67 motavizumab 67 peginesatide 67 synthetic retinoid 67 FOLFIRI 67 Golimumab 67 Spiegelmer ® 67 OMP #R# 67 divalproex sodium 67 Arixtra 67 PRIMO CABG 67 Virulizin ® 67 Jevtana 67 AMEVIVE 67 HCV NS5B polymerase 67 IFN α 67 PEGINTRON TM 67 CA4P 67 Sutent sunitinib 67 oxypurinol 67 ara C 67 Pegasys ® 67 Prostate AdenoCarcinoma Treatment 67 PROSTVAC TM 67 placebo controlled Phase 67 CRLX# 67 iclaprim 67 candesartan cilexetil 67 randomized multicenter Phase III 67 XOMA 3AB 67 ADP receptor antagonist 67 Blinatumomab 67 ALN HPN 67 CEQ# 67 Safinamide 67 TMC# [002] 67 MEK inhibitors 67 ISENTRESS 67 low dose cytarabine 67 MYDICAR 67 PF # [001] 67 OMP #M# 67 Roche Pegasys 67 Phase IIb III 67 aflibercept VEGF Trap 67 endothelin receptor antagonists 67 doxorubicin docetaxel 67 ThermoDox R 67 dosing cohort 67 sipuleucel T 67 pediatric acute lymphoblastic 67 RG# [001] 67 Dalbavancin 67 Valdoxan 67 lasofoxifene 67 albiglutide 67 Cloretazine 67 Thalomid ® 67 bevacizumab Avastin ® 67 Avanafil 67 Stedivaze 67 sodium thiosulfate STS 67 HspE7 67 INSPIRE Trial Phase III 67 active comparator 67 Aliskiren 67 ocular formulation 67 Xelox 67 randomized Phase 2b 67 VAPRISOL 67 abatacept Orencia 67 Cethromycin 67 DXL# 67 Femara letrozole 67 ATL# [002] 67 eosinophilic asthma 67 CYCLOSET 67 initiate Phase 1b 67 Myocet 67 ritonavir boosted danoprevir 67 PEGylated Fab fragment 67 vorinostat 67 PREZISTA r 67 Glypromate 67 evaluating Actimmune 67 Phase #b/#a clinical 67 rufinamide 67 liposomal doxorubicin 67 RAPTIVA R 67 Natalizumab 67 CCX# B 67 ORAL Sync 67 SUTENT ® 67 ARCALYST ® 67 novel histone deacetylase 67 MEND CABG 67 PA# [002] 67 lenalidomide Revlimid R 67 EVIZON 67 doripenem 67 Erbitux cetuximab 67 farletuzumab 67 QTc prolongation 67 faropenem 67 investigational compounds 67 alfa 2a 67 dose escalation Phase 67 Irinotecan 67 Actimmune R 67 plus dexamethasone 67 Urocidin TM 67 HIV integrase inhibitor 67 omacetaxine mepesuccinate 67 TPI ASM8 67 GLYX 67 systemically administered 67 pharmacokinetic PK 67 PROVENGE sipuleucel T 67 Fulvestrant 67 Tekamlo 67 mesylate 67 Vidaza R 67 SPARLON 67 Navelbine ® 66 TroVax ® 66 tivozanib 66 crizotinib PF # 66 FROVA 66 pivotal bioequivalence 66 Campath alemtuzumab 66 Noxafil 66 Nasulin 66 Vidaza azacitidine 66 AKT inhibitor 66 dasatinib 66 AZT zidovudine Retrovir 66 INTEGRILIN ® 66 HCV protease inhibitors 66 GRN# 66 SERMs 66 SAR# [002] 66 Copegus ribavirin 66 Civacir 66 Completes Patient Enrollment 66 sunitinib 66 ZK EPO 66 Deforolimus 66 IV APAP 66 DOXIL 66 tasocitinib 66 ACOMPLIA R 66 dose escalation clinical 66 plasma kallikrein inhibitor 66 HGS ETR1 mapatumumab 66 THR beta agonist 66 bazedoxifene 66 HSP# inhibitor 66 OvaRex R 66 Triapine R 66 fluvastatin 66 nilotinib 66 NV1FGF 66 recurrent GBM 66 Mylotarg 66 mitoxantrone plus 66 blinded randomized placebo controlled 66 selective modulator 66 Pegloticase 66 levosimendan 66 PRX # 66 indolent NHL 66 eprotirome 66 fosbretabulin 66 pharmacokinetic interactions 66 PegIFN RBV 66 APTIVUS ritonavir 66 corticosteroid dexamethasone 66 generation purine nucleoside 66 RoACTEMRA 66 PEP# [003] 66 IMGN# 66 Clolar ® 66 Sustiva efavirenz 66 bezafibrate 66 abacavir lamivudine 66 Methylnaltrexone 66 cMET 66 INCB# [003] 66 IIa trial 66 capecitabine Xeloda 66 samalizumab 66 phase III isavuconazole 66 dacarbazine 66 tramiprosate ALZHEMED TM 66 SCH # 66 antibody MAb 66 Q#IR 66 antiplatelet agent 66 glucokinase activator 66 leading oral taxane 66 Afatinib 66 Egrifta 66 afatinib 66 receptor modulators 66 Aganocide 66 hypoxia activated prodrug 66 Varespladib 66 midstage studies 66 Aclidinium 66 ThermoDox ® clinical 66 Ceflatonin 66 gamma secretase inhibitor 66 MAA submission 66 CCR5 antagonist 66 azacitidine 66 dexanabinol 66 bazedoxifene conjugated estrogens 66 IAP inhibitor 66 safinamide 66 Tarceva erlotinib 66 TOLAMBA 66 plus prednisone 66 Dyloject TM 66 oral FTY# 66 SARMs 66 esomeprazole Nexium 66 Synavive 66 FOLOTYN 66 oral nucleoside analogue 66 BCIRG 66 Zerenex 66 MAP# 66 Solazed 66 XL# SAR# 66 Vaprisol 66 Vandetanib 66 BMS # 66 Clonicel 66 CD# monoclonal antibody 66 investigational compound 66 Virulizin R 66 Arranon 66 Carfilzomib 66 plus DOXIL 66 CRx 66 Betaferon R 66 clevidipine 66 CINQUIL 66 MT# MEDI 66 PDX pralatrexate 66 evaluating REVLIMID 66 Vectibix panitumumab 66 mg/m2 dose 66 AZILECT R 66 Hematide ™ 66 hyperphenylalaninemia HPA due 66 Phase #/#a trial 66 Zenvia Phase III 66 PEGPH# 66 interferon alfa 66 lexidronam injection 66 lupus nephritis 66 Aviptadil 66 clinical pharmacology studies 66 Tarvacin TM 66 AERx iDMS 66 Ramoplanin 66 non metastatic osteosarcoma 66 G#DT 66 Seliciclib